$0.32−0.03 (−7.63%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD
Redhill Biopharma (RDHL) Stock
Redhill Biopharma (RDHL) closed at $0.32 on Nov 19, 2026.
Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice
Key stats
- Close
- $0.32
- Nov 19, 2026
- 52-week range
- 0.30 – 1.60
- low → high
Industry: Drugs · see every company filed here →
Redhill Biopharma Ltd. is not scored This company's figures fail our cross-checks, so its Tenet Score and ratios are withheld.
Tenet Score
This company's figures fail our cross-checks, so its Tenet Score and ratios are withheld. Statements are shown as our data vendor supplies them.
Price
Loading chart…
P/E
—
Withheld: our cross-checks of this company's figures disagree.
P/B
—
Withheld: our cross-checks of this company's figures disagree.
P/S
—
our cross-checks of this company's figures disagree, so it is withheld
ROE
—
Withheld: our cross-checks of this company's figures disagree.
Operating margin
—
our cross-checks of this company's figures disagree, so it is withheld
Net margin
—
Withheld: our cross-checks of this company's figures disagree.
Current ratio
—
Withheld: our cross-checks of this company's figures disagree.
Net debt / EBITDA
—
Withheld: our cross-checks of this company's figures disagree.
EPS CAGR 5y
—
our cross-checks of this company's figures disagree, so it is withheld
Market cap
—unverified basis
share basis not confirmed
Div yield
—
our cross-checks of this company's figures disagree, so it is withheld
The whole report, at a glance · every card is a live peek, click any to open the section
Tenets
Not evaluated: our cross-checks of this company's figures disagree.
Financials
Revenue, margins and the five-year statements.Analyst Forecasts
No consensus on the current plan.
Earnings
TBA
next reportBeat/miss history appears here after the first tracked report.Statistics
No ratios yet.Technical Analysis
Downtrend short-term signalvs 50-day−31.3%
vs 200-day−56.8%
RSI (14)30
News & Insights
Recent headlines with their publishers and dates.Dividends
Pays no dividend. Every dollar of profit is reinvested into the business.Ownership
13F summary not ready yet. It appears here within a few minutes.About Redhill Biopharma Ltd.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer p…
Composite computed Nov 20, 2026 · peer basis: Healthcare (n=487) · every glimpse links to its full section with sources · not investment advice.
Common questions
What sector and industry is Redhill Biopharma in?
Redhill Biopharma is in the Healthcare sector and the Drugs industry.




